SynthesisFrontiers in immunology2026
Before-treatment body mass index as a prognostic factor in cancer patients receiving immune checkpoint inhibitors: a systematic review and dose-response meta-analysis.
Siyu Sun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.